Navigation Links
AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Date:12/6/2012

ll not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About AcelRx Pharmaceuticals, Inc.
AcelRx Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain.

Forward Looking Statements
Certain of the statements made in this press release are forward looking, such as those, among others, relating to AcelRx's expectations regarding the completion, timing and size of the public offering and the amount of gross proceeds to be received. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include, without limitation, risks and uncertainties related to market and other conditions, the satisfaction of customary closing conditions related to the public offering and the impact of general economic, industry or political conditions in the United States or internationally. There can be no assurance that AcelRx will be able to complete the public offering at the anticipated size or on the anticipated terms, or at all. AcelRx will need to raise additional capital to fund its operations and may be unable to raise capital when needed, which would force AcelRx to delay, reduce or eliminate its product development programs or commercialization efforts. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this press release.  Additional risks and uncertainties relating to the proposed offering, AcelRx and its business can be found under the heading "Risk Factors" in the prospectus inclu
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results
2. AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing
3. AcelRx Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
4. AcelRx Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
5. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
6. AcelRx Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call and Webcast on August 9, 2012
7. AcelRx Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Healthcare Conference
8. AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
9. AcelRx Pharmaceuticals to Present at Three Upcoming Investor Conferences
10. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
11. AcelRx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium Research ... market intelligence, the United States ... device markets will expand moderately through 2022, with ... In particular, increasing interest in drug-eluting beads (DEBs) ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... - India Drug Forecast and Market Analysis ... PharmaPoint: Atopic Dermatitis - India ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Delivery Systems -- Focus on End Users ... STUDY OBJECTIVES A drug delivery ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
... Feb. 28, 2012  Today, Jeanne Monahan , ... Human Dignity , testified before the House Judiciary Committee ... titled "Executive Overreach: The HHS [Department of Health and ... excerpts from her testimony: (Logo: ...
... Company (Nasdaq: PRGO;TASE) today announced its Chairman & CEO ... Healthcare Conference on Wednesday, February 29th, at 3:30 PM ... York City, New York. Perrigo Company ... and distributes OTC and generic prescription (Rx) pharmaceuticals, infant ...
Cached Medicine Technology:FRC's Jeanne Monahan Testifies Before House Judiciary Committee, Urges Repeal of Discriminatory Mandate 2Perrigo Company to Present at the RBC Capital Markets' Healthcare Conference 2
(Date:7/11/2014)... (PRWEB) July 11, 2014 Wild by Nature, ... proud to announce they are opening a fifth store to ... by Nature offers one of the largest selections of wheat ... diagnosed with celiac disease, these stores have become a one-stop ... diet. , Gluten sensitivity, and gluten intolerance, is a spectrum ...
(Date:7/11/2014)... CA (PRWEB) July 11, 2014 The World ... according to recent reports , many star soccer players ... backseat in the media to American football when it comes ... the risk is always there. While none of the soccer ... the possibility remains. Beverly Hills spine surgeon Dr. Gravori reveals ...
(Date:7/11/2014)... July 11, 2014 Wearing the school motto ... families, facility and staff came together this past Saturday morning ... Everest community in the Homer Township Independence Day Parade. ... Old Glory. , Everest community recognized the theme ... in red, white and blue. The blue Everest balloons ...
(Date:7/11/2014)... 11, 2014 The International Concussion ... at the Best Buy Theater in Times Square, ... to the growing concussion epidemic that is plaguing ... levels of competition. , The Symposium gathers more ... researchers, coaches, professional athletes and legal scholars for ...
(Date:7/11/2014)... Dallas, TX (PRWEB) July 11, 2014 ... development of blood products industry. Although the closure of ... cause major disruption to domestic blood products market, the ... by 2.8% year on year and total lot release ... 2013, due to stock consumption, insufficient utilization of new ...
Breaking Medicine News(10 mins):Health News:Wild by Nature Opens New Location 2Health News:As World Cup Comes to an End, Injuries are Star of the Show 2Health News:As World Cup Comes to an End, Injuries are Star of the Show 3Health News:Everest Academy Participates in the Homer Township Independence Day Parade 2Health News:The International Concussion Organization 501(c)(3) hosts its 1st Annual Concussion Symposium at the Best Buy Theater in Time Square, NYC, July 17th, 2014. 2Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 2Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 3Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 4
... Block Imaging International,Inc. has formed a strategic ... a new line of medical imaging digital solutions., ... of used and refurbished,medical imaging equipment -- will ... CR and archive solutions from Dicom Solutions, Inc. ...
... BETHESDA, Md., Sept. 22 Hanger Orthopedic,Group, Inc. (NYSE: ... 2,500,000,shares of its common stock by Ares Corporate Opportunities ... the currently outstanding shares,issued to Ares in August 2008 ... A Convertible Preferred Stock into common stock. Upon,completion of ...
... Sept. 22 An improved and more,accessible version ... help,people stay healthy, was launched today by the ... Its new design and interactive health management tools ... for consumers and,professionals., "Many Americans struggle with ...
... more likely to experience trouble, study finds , , MONDAY, ... cholesterol-lowering statin drugs -- which include Crestor, Lipitor, Pravachol ... after surgery, a Canadian study indicates. , Delirium is ... after any sort of surgery, according to study lead ...
... 22, Focuses on Preventing Falls to Older,Adults, ... to action urging government, citizens and healthcare,professionals to ... of falls,among people 65 years of age and ... as well as Representatives Frank Pallone (D-NJ) and,Ralph ...
... the 2006 Medicare Current Beneficiary Survey, WASHINGTON, ... option for low and moderate income seniors and ... data from the Medicare,Current Beneficiary Survey (MCBS)., ... and those,living in rural areas, rely on Medigap ...
Cached Medicine News:Health News:Block Imaging International, Inc. Partners with Dicom Solutions, Inc. to Offer New Products 2Health News:Hanger Orthopedic Group, Inc. Announces Underwritten Public Offering by Shareholder 2Health News:Hanger Orthopedic Group, Inc. Announces Underwritten Public Offering by Shareholder 3Health News:Improved healthfinder.gov Makes Health Information Quicker and Easier to Use 2Health News:Improved healthfinder.gov Makes Health Information Quicker and Easier to Use 3Health News:Cholesterol Drugs May Raise Post-Op Delirium Risk 2Health News:Cholesterol Drugs May Raise Post-Op Delirium Risk 3Health News:Home Safety Council(R) Applauds Creation of Falls Prevention Awareness Day 2
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features: Eppendorf ...
... Seven digital models cover the range from 2ul ... fluently. Volume lock design prevents inadvertent volume ... horizontal grip. Whole pipette is autoclavable at ... is all polypropylene. Suitable for one-handed operation. ...
... a fully adjustable, air-displacement pipette with a ... latest member of the Pipetman family, sharing ... and precision. We also added a number ... customers. Eight models cover the full range ...
Medicine Products: